How the APAC Surgical Procedure Database is Transforming Healthcare Decision-Making
BIS Research, a global leader in deep-technology market intelligence and advisory, today unveiled its APAC Surgical Procedure Volume Database, the most comprehensive and dynamic repository of surgical data across the Asia-Pacific region. Designed to support healthcare innovators, MedTech manufacturers, and research institutions, the platform provides a data-driven foundation for precision medicine strategy, hospital benchmarking, and market forecasting.
Built on validated primary research and multi-source healthcare analytics, the Surgical Procedure Volume Database Asia-Pacific delivers reliable surgical procedure volume data across 40+ countries, covering North America, Europe, Asia-Pacific, Latin America, and emerging markets and 13+ surgical specialties, hundreds of procedures, and dozens of specialties. The platform allows users to buy APAC surgical procedure database access and leverage continuous updates through the medtech companies APAC surgery demand data offering—empowering faster, evidence-based decisions.
Country-Level Insights: Data That Drives Precision
The APAC Surgical Procedure Volume Database by BIS Research continues to deliver real-time visibility into how surgical activity is evolving across Asia-Pacific.
Regional Overview
According to BIS Research’s APAC Surgical Procedure Volume Database, estimated figures reveal significant regional variations across Asia-Pacific healthcare systems:
Asia-Pacific Markets — Key Insights
The APAC Surgical Procedure Volume Database by BIS Research provides a deep, data-driven view of surgical trends, procedural volumes, and technology adoption across Asia-Pacific.
It helps hospitals, MedTech companies, and policymakers make smarter, evidence-based decisions in healthcare planning and investment.
Breast Cancer Surgical Procedures (2023–2024 Estimates)
South Korea:
2023 - 16,489
2024 - 16,919
Japan:
2023 - 53,244
2024 - 55,131
Australia:
2023 - 11,802
2024 - 12,208
Insight:
Japan dominates regional volumes due to strong national screening programs.
South Korea and Australia show steady increases in breast oncology surgeries, reflecting improved early detection and patient access.
Breast Implant Reconstruction Procedures (2023–2024 Estimates)
South Korea:
2023 - 5,058
2024 - 5,220
Japan:
2023 - 15,534
2024 - 15,939
Australia:
2023 - 7,272
2024 - 7,490
Insight:
Consistent growth across all three countries highlights increasing focus on post-cancer reconstructive care and aesthetic recovery.
Driven by higher patient awareness and advanced reconstructive technologies.
ENT Surgical Procedures
Cochlear Implant Procedures (2023–2024 Estimates)
South Korea:
2023 - 314
2024 - 352
Japan:
2023 - 1,618
2024 - 1,781
Australia:
2023 - 2,648
2024 - 2,943
Mastoidectomy Procedures (2023–2024 Estimates)
Japan:
2023 - 14,259
2024 - 14,741
Australia:
2023 - 545
2024 - 566
New Zealand:
2023 - 1,555
2024 - 1,612
Insight:
Australia leads in cochlear implant adoption due to strong reimbursement policies.
Japan shows the highest ENT procedure volume regionally, indicating mature ENT infrastructure and high patient throughput.
Organ Transplant Procedures
Liver Transplants (2023–2024 Estimates)
South Korea:
2023 - 1,497
2024 - 1,604
Japan:
2023 - 470
2024 - 506
Australia:
2023 - 287
2024 - 308
Heart Transplants (2023–2024 Estimates)
South Korea:
2023 - 245
2024 - 275
Japan:
2023 - 115
2024 - 130
Australia:
2023 - 129
2024 - 146
Lung Transplants (2023–2024 Estimates)
South Korea:
2023 - 202
2024 - 231
Japan:
2023 - 128
2024 - 147
Australia:
2023 - 164
2024 - 189
Insight:
South Korea leads APAC in transplant volume growth, supported by advanced infrastructure and government-led donor programs.
Regional increase in transplant procedures underscores improved survival outcomes and expanding surgical expertise.
Urology Procedures
Renal Artery Bypass (2023–2024 Estimates)
South Korea:
2023 - 484
2024 - 529
Japan:
2023 - 873
2024 - 938
Australia:
2023 - 444
2024 - 485
Prostatectomy (2023–2024 Estimates)
South Korea:
2023 - 13,290
2024 - 14,353
Japan:
2023 - 12,946
2024 - 13,788
Australia:
2023 - 12,985
2024 - 13,764
Insight:
Urology volumes continue to climb due to aging male populations and rising cancer screening rates.
Robotic-assisted surgery adoption is accelerating in Japan and South Korea, improving surgical precision and recovery outcomes.
Drive Smarter Decisions – Get the Database Today - Request a Quote
Regional Takeaways
Steady growth across high-income APAC markets highlights post-pandemic recovery and healthcare modernization.
Japan remains a surgical powerhouse, with top volumes in oncology and ENT.
South Korea leads in transplant and urology growth, showcasing innovation in complex surgery.
Australia consistently advances precision and robotic surgery adoption.
Data-backed decisions enable better forecasting, infrastructure planning, and precision medicine integration.
Surgical Procedure Volume Database — Access Options & Licensing
BIS Research offers flexible database access options designed to match your organization’s research depth, regional focus, and strategic needs.
Each database provides validated, country-level procedure data with annual updates, expert verification, and analytics-ready formats.
Single Database Access
Ideal for focused insights within a specific specialty and country.
Coverage: Any one specialty in one country
Includes: Annual procedure volumes, forecasts (2023–2030), and YoY trends
Price: USD 2,450
Country-Wide Access — All Specialties
Comprehensive national view of all surgical disciplines.
Coverage: All specialties for any one country
Includes: Over 300 procedures across 14 specialties, with detailed hospital and surgeon data
Price: USD 5,850
Global Specialty Access
For companies or researchers focusing on one surgical discipline across international markets.
Coverage: Any one specialty across 40+ countries
Includes: Global benchmarking, regional comparison, and procedure growth analytics
Price: USD 7,850
Global Surgical Procedure Volume Database
The ultimate solution website for multi-country surgical intelligence and precision healthcare analysis.
Coverage: All 300+ procedures across 14 specialties and 40+ countries
Includes: Global, regional, and country-level analytics dashboards; forecasting through 2030
Price: USD 18,850
Bridging Surgical Intelligence and Precision Medicine
As the precision medicine era accelerates, the integration of surgical and genomic data is transforming healthcare planning. BIS Research’s surgical trends database Asia-Pacific and precision medicine surgery data by indication APAC modules help stakeholders understand this convergence in detail.
Through the personalized medicine surgical adoption database, organizations can track trends in robotic-assisted, AI-guided, and genomic-based surgeries, identifying where precision interventions are scaling fastest. The APAC precision treatment and surgical database connects country-level procedure data with precision-medicine infrastructure to reveal adoption readiness and growth potential across markets.
Additionally, the precision medicine surgery volume data APAC module quantifies procedure-level demand linked to personalized treatment pathways, offering insights for R&D prioritization and investment planning.
Hospital & Physician-Level Intelligence
Access data from 4,000+ hospitals globally—enabling hospital-level analytics
Identify key institutions and high-volume practitioners for refined targeting and partnerships
Request a Demo
About BIS Research
BIS Research, recognized as a top market research company, specializes in market research reports and advisory services focused on deep technology and emerging trends that are poised to disrupt key industrial markets. Annually, we publish over 200 market intelligence reports across various deep technology verticals. We help businesses stay ahead with in-depth reports, custom research, and go-to-market strategies tailored to your goals.